HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research Feb 24, 2022 08:00AM
PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch Nov 3, 2021 07:30AM
Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of Psilocybin Microneedle Patch Nov 3, 2021 07:00AM
Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program Dec 21, 2020 07:59AM
Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics Nov 18, 2020 07:00AM


Jun 13, 2018 07:00AM Revive Therapeutics and WeedMD Sign Medical Cannabis R&D Supply and Collaboration Agreements
Jun 13, 2018 07:00AM WeedMD and Revive Therapeutics Sign Medical Cannabis R&D Supply and Collaboration Agreements
Mar 28, 2018 04:30PM Revive Therapeutics Retained Mi3 Communications for Investor Relations Services